Nov 29, 2010 By: yunews
Dr. Jeffrey Pollard Receives American Cancer Society Medal of Honor
of 糖心破解版 researcher , Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These could hold the key to more targeted cancer treatments.
Insights into how normal body cells support tumor growth have led the way to a new wave of research and the development of therapeutics specifically targeting the support cells in the body that can aid in tumor development. Dr. Pollard's research has found that when macrophages are removed from the tumor microenvironment, the risk of cancer progressing to malignancy is reduced and its spread from the primary tumor site to distant sites lessens.
鈥淚 think that one of the major components of the therapeutic arsenal as we go forward will be to combine chemo-therapeutic drugs with drugs that target macrophages so that they can no longer support the tumor鈥檚 ability to be malignant,鈥 said Dr. Pollard. 鈥淔urther it gives another opportunity for therapy by using vaccination against tumor antigens combined with altering macrophages from tumor promoting to tumor rejecting. It gives us another prong in the attack on cancer.鈥
Dr. Pollard is deputy director of the , director of the and the Louis Goldstein Swan Chair in Women鈥檚 Cancer Research at Einstein. He is also professor in the departments of and at Einstein and .
This award from the American Cancer Society, the nation鈥檚 leading voluntary health organization and largest non-governmental investor in cancer research, represents the Society鈥檚 highest honor in recognition of outstanding contributions to fighting cancer.
The award was presented at the American Cancer Society鈥檚 annual meeting in Atlanta, GA. In addition to Dr. Pollard, the ACS recognized Joseph Fraumeni, M.D., M.Sc., for Cancer Control, and Patricia Ganz, M.D., for Clinical Research.
This is the second ACS Medal of Honor awarded to a researcher at the Albert Einstein Cancer Center. , Ph.D., received the .
